Search

everythinglearnresearchcommunity

for

Search:↓

HAT-MSCs can effectively engulf harmful microbes and particles, aiding infection treatment.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

Mediterranean Erica plants may help with inflammation, infections, and weight loss due to their bioactive compounds.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

Vaccination is crucial for public health, but anti-vaccine movements are a concern.

Blood cells turned into stem cells can become skin cells similar to normal ones, potentially helping in skin therapies.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Itraconazole may cause low platelet and white blood cell counts.

Instagram® effectively spreads awareness about onychomycosis.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Boreal caribou in northeastern British Columbia have significant health issues, including infections, tick infestations, and mineral deficiencies.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Most COVID-19 survivors developed post-acute symptoms, especially if they had been in the ICU, but the severity of initial infection didn't predict these symptoms.

Mediterranean Erica species have compounds that support their traditional use for health benefits like reducing inflammation and fighting infections.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Malarone® caused pancreatitis and hair loss in a dog for the first time.